You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

Article metrics

Article menu

Download PDFPDF

Research Article
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019220
Jan 202011110
Feb 202032326
Mar 202035358
Apr 202034346
May 202036365
Jun 2020404021
Jul 2020424210
Aug 2020413910
Sep 2020696921
Oct 202010610616
Nov 2020898923
Dec 202014814823
Jan 202114414428
Feb 202126226214
Mar 202115615639
Apr 2021828248
May 2021979725
Jun 202112212239
Jul 2021949426
Aug 202111511544
Sep 2021717135
Oct 2021959551
Nov 2021727235
Dec 2021798336
Jan 2022444522
Feb 2022474918
Mar 2022374222
Apr 2022252624
May 2022444419
Jun 2022343511
Jul 202234358
Aug 202248528
Sep 2022586524
Oct 2022536524
Nov 2022313112
Dec 20221021028
Jan 2023363613
Feb 2023434314
Mar 202345468
Apr 2023151613
May 202313135
Jun 202318194
Jul 2023141613
Aug 202318189
Sep 202317176
Oct 202326267
Nov 202318184
Dec 202335367
Jan 202440415
Feb 202435355
Mar 2024363612
Total30403083894